Related Experiment Video
Updated: Jun 5, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
IgG4-related disease for the hematologist
1Division of Hematology, University of British Columbia, Vancouver, British Columbia, Canada; and Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.
Immunoglobulin G4-related disease (IgG4-RD) presents with hematologic issues like polyclonal hypergammaglobulinemia and lymphadenopathy. Differentiating IgG4-RD from similar conditions is crucial for effective treatment.
Area of Science:
- Immunology
- Pathology
- Rheumatology
Background:
- Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition affecting multiple organs, notably hematopoietic and lymphoid tissues.
- Key diagnostic features include increased IgG4-positive plasma cells in tissues, elevated serum IgG and IgG4, storiform fibrosis, lymphoplasmacytic infiltrate, eosinophilia, and obliterative phlebitis.
- IgG4-RD can manifest as proliferative diseases (e.g., autoimmune pancreatitis) or fibrotic conditions (e.g., retroperitoneal fibrosis).
Purpose of the Study:
- To review the four main hematological manifestations of IgG4-RD: polyclonal hypergammaglobulinemia (PHGG), IgG4-positive plasma cell enriched lymphadenopathy (LAD), eosinophilia, and retroperitoneal fibrosis (RPF).
- To provide an organized approach for distinguishing IgG4-RD from its hematological mimics.
- To highlight the importance of accurate diagnosis for appropriate treatment strategies.
Main Methods:
- Review of literature focusing on the hematological manifestations of IgG4-RD.
- Analysis of key diagnostic criteria, including histological findings and serological markers.
- Comparison of IgG4-RD with its common hematological mimics such as Castleman disease, eosinophilic vasculitis, hypereosinophilic syndromes, and histiocyte disorders.
Main Results:
- PHGG, LAD, eosinophilia, and RPF are present in 70%, 60%, 40%, and 25% of IgG4-RD patients, respectively.
- These hematological features can also mimic IgG4-RD, presenting diagnostic challenges.
- An organized diagnostic approach is essential to differentiate IgG4-RD from conditions like Castleman disease and hypereosinophilic syndromes.
Conclusions:
- Hematological manifestations are common in IgG4-RD and can also mimic the disease, necessitating careful evaluation.
- Distinguishing IgG4-RD from its mimics is critical for guiding treatment decisions.
- Proliferative IgG4-RD forms respond well to immunosuppressive therapy, while fibrotic changes may be irreversible.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Hematopoiesis
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

